July 21, 2026 - PRESSADVANTAGE - Hera Fertility has been selected for the Mayo Clinic Platform Accelerate program, a ...
Sana Biotechnology's lead asset still remains to be SC291, repurposed for severe autoimmune disorders instead of blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results